APA (7th ed.) Citation

AA, A., M, S., BA, A., EM, E., HS, E., A, A., . . . GG, A. (2026). Comparative Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Agonists on Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Cureus, 18(1), e100927. https://doi.org/10.7759/cureus.100927

Chicago Style (17th ed.) Citation

AA, Alqurain, et al. "Comparative Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Agonists on Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis." Cureus 18, no. 1 (2026): e100927. https://doi.org/10.7759/cureus.100927.

MLA (9th ed.) Citation

AA, Alqurain, et al. "Comparative Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Agonists on Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis." Cureus, vol. 18, no. 1, 2026, p. e100927, https://doi.org/10.7759/cureus.100927.